Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 14, 2019
DNA methylation genome-wide analysis in remnant and primary gastric cancersKiichi Sugimoto, Tomoaki Ito, Alicia Hulbert, et al.Anticancer Research|January 30, 2022
CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal CancerToshiaki Hagiwara, Kiichi Sugimoto, Hirotaka Momose, et al.Anticancer Research|May 27, 2026
Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon CancerYuta Murai, Kiichi Sugimoto, Takahiro Irie, et al.Anticancer Research|July 27, 2023
Positive Circumferential Resection Margin in Rectal Cancer Is a Robust Predictor of Poor Long-term Prognosis With Clinicopathological Bias Between Groups Compensated by Propensity-score Matching AnalysisKiichi Sugimoto, Hiromitsu Takahashi, Yuki, et al.Cancers|June 12, 2026
Clinical Impact of Baseline ctDNA RAS/BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal CancerTakeshi Yamada, Takeshi Nagasaka, Nobuhisa Matsuhashi, et al.Surgery Today|February 9, 2023
Examination of colorectal cancer cases with metal allergyKosuke Mizukoshi, Yu Okazawa, Kota Amemiya, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2014
[A case of cecum colon cancer with lymph node metastasis successfully treated with XELOX plus bevacizumab]Shingo Ito, Ryosuke Ichikawa, Kazumasa Kure, et al.Oncology Letters|January 20, 2017
Impact of chromosome 17q deletion in the primary lesion of colorectal cancer on liver metastasisMasaya Kawai, Hiromitsu Komiyama, Masaki Hosoya, et al.International Journal of Clinical Oncology|May 31, 2022
Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study)Shun Ishiyama, Takeshi Yamada, Masato Nakamura, et al.Scientific Reports|January 9, 2024
NTRK2 expression in gastrointestinal stromal tumors with a special emphasis on the clinicopathological and prognostic impactsKeita Sasa, Raku Son, Akiko Oguchi, et al.Pageof 11